| Code |
Title |
|
–
|
Top Categories
|
|
3 |
Administration
|
|
3E |
Physiological Systems and Anatomical Regions
|
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
|
3E0E |
Products of Conception
|
|
3E0E3 |
Percutaneous
|
|
3E0E30 |
Antineoplastic
|
|
3E0E304
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Percutaneous Approach
|
|
3E0E305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach
|
|
3E0E30M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach
|
|
3E0E32 |
Anti-infective
|
|
3E0E328
|
Oxazolidinones
Introduction of Oxazolidinones into Products of Conception, Percutaneous Approach
|
|
3E0E329
|
Other Anti-infective
Introduction of Other Anti-infective into Products of Conception, Percutaneous Approach
|
|
3E0E33 |
Anti-inflammatory
|
|
3E0E33Z
|
No Qualifier
Introduction of Anti-inflammatory into Products of Conception, Percutaneous Approach
|
|
3E0E36 |
Nutritional Substance
|
|
3E0E36Z
|
No Qualifier
Introduction of Nutritional Substance into Products of Conception, Percutaneous Approach
|
|
3E0E37 |
Electrolytic and Water Balance Substance
|
|
3E0E37Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Products of Conception, Percutaneous Approach
|
|
3E0E3B |
Anesthetic Agent
|
|
3E0E3BZ
|
No Qualifier
Introduction of Anesthetic Agent into Products of Conception, Percutaneous Approach
|
|
3E0E3G |
Other Therapeutic Substance
|
|
3E0E3GC
|
Other Substance
Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Approach
|
|
3E0E3H |
Radioactive Substance
|
|
3E0E3HZ
|
No Qualifier
Introduction of Radioactive Substance into Products of Conception, Percutaneous Approach
|
|
3E0E3K |
Other Diagnostic Substance
|
|
3E0E3KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Products of Conception, Percutaneous Approach
|
|
3E0E3N |
Analgesics, Hypnotics, Sedatives
|
|
3E0E3NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Percutaneous Approach
|
|
3E0E3S |
Gas
|
|
3E0E3SF
|
Other Gas
Introduction of Other Gas into Products of Conception, Percutaneous Approach
|
|
3E0E3T |
Destructive Agent
|
|
3E0E3TZ
|
No Qualifier
Introduction of Destructive Agent into Products of Conception, Percutaneous Approach
|
|
3E0E4 |
Percutaneous Endoscopic
|
|
3E0E4G |
Other Therapeutic Substance
|
|
3E0E4GC
|
Other Substance
Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Endoscopic Approach
|
|
3E0E7 |
Via Natural or Artificial Opening
|
|
3E0E70 |
Antineoplastic
|
|
3E0E704
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E705
|
Other Antineoplastic
Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E70M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E72 |
Anti-infective
|
|
3E0E728
|
Oxazolidinones
Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E729
|
Other Anti-infective
Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E73 |
Anti-inflammatory
|
|
3E0E73Z
|
No Qualifier
Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E76 |
Nutritional Substance
|
|
3E0E76Z
|
No Qualifier
Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E77 |
Electrolytic and Water Balance Substance
|
|
3E0E77Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E7B |
Anesthetic Agent
|
|
3E0E7BZ
|
No Qualifier
Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E7G |
Other Therapeutic Substance
|
|
3E0E7GC
|
Other Substance
Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E7H |
Radioactive Substance
|
|
3E0E7HZ
|
No Qualifier
Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E7K |
Other Diagnostic Substance
|
|
3E0E7KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E7N |
Analgesics, Hypnotics, Sedatives
|
|
3E0E7NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E7S |
Gas
|
|
3E0E7SF
|
Other Gas
Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E7T |
Destructive Agent
|
|
3E0E7TZ
|
No Qualifier
Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening
|
|
3E0E8 |
Via Natural or Artificial Opening Endoscopic
|
|
3E0E80 |
Antineoplastic
|
|
3E0E804
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E805
|
Other Antineoplastic
Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E80M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E82 |
Anti-infective
|
|
3E0E828
|
Oxazolidinones
Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E829
|
Other Anti-infective
Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E83 |
Anti-inflammatory
|
|
3E0E83Z
|
No Qualifier
Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E86 |
Nutritional Substance
|
|
3E0E86Z
|
No Qualifier
Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E87 |
Electrolytic and Water Balance Substance
|
|
3E0E87Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E8B |
Anesthetic Agent
|
|
3E0E8BZ
|
No Qualifier
Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E8G |
Other Therapeutic Substance
|
|
3E0E8GC
|
Other Substance
Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E8H |
Radioactive Substance
|
|
3E0E8HZ
|
No Qualifier
Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E8K |
Other Diagnostic Substance
|
|
3E0E8KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E8N |
Analgesics, Hypnotics, Sedatives
|
|
3E0E8NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E8S |
Gas
|
|
3E0E8SF
|
Other Gas
Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening Endoscopic
|
|
3E0E8T |
Destructive Agent
|
|
3E0E8TZ
|
No Qualifier
Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic
|